Numen vs Singlera Genomics Incorporated

Numen

Engineering a future without cancer deaths

18 employees · est. 2021 · San Francisco, United States

Singlera Genomics Incorporated

Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA)

30 employees · est. 2013 · La Jolla, United States

Singlera Genomics Incorporated is the older company (2021 vs 2013).

Side-by-Side Comparison

Metric	Numen	Singlera Genomics Incorporated
Founded
Founded	2021	2013 older
Headquarters
Headquarters	San Francisco, United States	La Jolla, United States
Employees
Employees	18	30
Industry
Industry	Health Care	Biotechnology, Health Care
Funding Stage
Funding Stage	Pre-Seed	Series B
Total Funding
Total Funding	$5.00M	$530.00M
Funding Rounds
Funding Rounds	1	6
Services
Services	Rapid at-home diagnostics, Health data collection, Proprietary predictive models	Not tracked yet
Target Customers
Target Customers	Healthcare providers, Cancer patients, Research institutions, Healthcare data analysts	Not tracked yet
Taxonomy
Taxonomy	Synthetic BiologyCancer ScreeningAt-Home DiagnosticsLab-Grade TestingCancer BiomarkersUrine Analysis +8	Liquid BiopsyCtmDNAMethylation HaplotypingAssay DevelopmentNGSMolecular Diagnostics +9
Website
Website	numen.com	singleragenomics.com

About Numen

Numen specializes in developing advanced health care solutions with a focus on synthetic biology and cancer screening. Based in San Francisco, United States, the company caters to healthcare providers, cancer patients, research institutions, and healthcare data analysts. Founded in 2021, Numen prov...

View Full Profile Alternatives

About Singlera Genomics Incorporated

Singlera Genomics Incorporated is at the forefront of early cancer detection with its pioneering liquid biopsy technologies. With a slogan to "Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA)," the company is focused on developing innovative reagents and bioinformati...

View Full Profile

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Numen and Singlera Genomics Incorporated for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Numen or Singlera Genomics Incorporated moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Frequently Asked Questions

Numen was founded in 2021, based in San Francisco, United States, with 18 employees. Numen specializes in developing advanced health care solutions with a focus on synthetic biology and cancer screening. Based in San Francisco, United States, the company caters to healthcare providers. Singlera Genomics Incorporated was founded in 2013, based in La Jolla, United States, with 30 employees. Singlera Genomics Incorporated is at the forefront of early cancer detection with its pioneering liquid biopsy technologies. With a slogan to "Detect cancer earlier with the power of circulating tumor.

Numen has raised $5.00M and Singlera Genomics Incorporated $530.00M. Latest stage: Numen Pre-Seed, Singlera Genomics Incorporated Series B.

Both work in Health Care and list cancer screening among their focus areas.

Compare Numen with someone else

Start typing a company name or domain.

Related Comparisons

Singlera Genomics Incorporated vs PreCyte Inc Singlera Genomics Incorporated vs ImmunoChemistry Technologies, LLC Numen Alternatives All Companies All Signals

Compiled from the BounceWatch company index. We last looked at Numen on 7 Apr 2026, and Singlera Genomics Incorporated on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.